ITGAX and neoplasm: We defined several immune subsets from the spleen and tumor by using CD8b, Thy1.1, PD-1, NK1.1, CD11b, CD11c, MHC-II, CD80, Ly6G, Ly6C, F4/80, and CD206 antibodies (Figure 4A and Figure 5A).